INNOMEDICA

Using InnoMedicaโs patented technology of a highly innovative drug delivery system, active pharmaceutical agents that were previously applied systemically can now be transported selectively to the affected area and released locally. Developing a new generation of medication, for example, cancer can be treated much more effective, while at the same time side effects for patients are reduced to a minimum.
INNOMEDICA
Industry:
Alternative Medicine Nanotechnology Pharmaceutical
Founded:
2000-01-01
Address:
Zug, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.innomedica.com
Total Employee:
1+
Status:
Active
Contact:
+41 31 311 04 27
Email Addresses:
[email protected]
Total Funding:
23.48 M USD
Technology used in webpage:
Domain Not Resolving Nginx Euro Amazon Amazon Frankfurt Region Plesk Nuxt.js 3 To 9 CcTLD Redirects Vercel
Similar Organizations
Aptar Pharma
Aptar Pharma is a solution provider of innovative drug delivery systems.
Medimetrics
Medimetrics is the pioneer and global leader in electronic oral drug delivery.
Sasta Sundar
Buy Genuine prescription medicine online & save big with free home delivery. India's fastest growing & most trusted Online Pharmacy.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.innomedica.com
- Host name: s050.cyon.net
- IP address: 149.126.4.59
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich

More informations about "Innomedica"
InnoMedica โ Pharmaceuticals efficiently targeted
InnoMedica uses nanocarriers to ensure that the various active ingredients are released precisely at the point of destination. This is intended to achieve an improved effect with reduced side effects. InnoMedica believes this will solve โฆSee details»
About InnoMedica | InnoMedica
InnoMedica was originally founded in 2000 as a finance company with headquarters in Zug, Switzerland. Initially, the company focused on its investments in biochemistry and medicine. โฆSee details»
Company | InnoMedica
The Swiss pharmaceutical company InnoMedica is defined through the will of a team to develop drugs from innovative research in the field of nanotransport systems and based on own patent โฆSee details»
Über uns - InnoMedica
As early as December 2017, InnoMedica protected the second application, which is aimed at the treatment of neurodegenerative diseases such as Parkinson's, with a patent and conducted further research for the drug. In 2020 and 2021, โฆSee details»
Innomedica - Crunchbase Company Profile & Funding
Organization. Innomedica . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. InnoMedicaโs patented technology of a highly โฆSee details»
Team | InnoMedica
Today the InnoMedica team consists of 51 employees - all with university degrees or many years of experience. InnoMedicaโs strong technical focus is reflected in the 31 employees with โฆSee details»
InnoMedica โ Pharmaceuticals efficiently targeted
InnoMedica verfolgt mittels Nanocarriern das Ziel, dass die verschiedenen Wirkstoffe erst am Ort der Bestimmung präzise freigesetzt werden. Dadurch soll eine verbesserte Wirkung bei gleichzeitig reduzierten Nebenwirkungen โฆSee details»
InnoMedica Holding AG - Swiss Biotech
Based on the liposomal technology platform, InnoMedica has built a diversified pipeline with lead compounds in oncology and neurodegenerative diseases. Clinical trials for the treatment of breast cancer as well as Parkinson's disease โฆSee details»
InnoMedica 2025 Company Profile: Valuation, Funding โฆ
InnoMedica General Information Description. Operator of a pharmaceutical company intended to provide patients with effective improvements in therapy. The company offers nanotechnology for the targeted treatment of diseases, โฆSee details»
Investoren โ InnoMedica
The InnoMedica Holding AG share (Valor: 55.897.390; ISIN: CH0558973902) is a registered share electronically booked into the respective shareholder's portfolio. The InnoMedica share is an unlisted, freely tradable security. There are โฆSee details»
InnoMedica Holding AG - LinkedIn
InnoMedica is a Swiss pharmaceutical company and established player in nanomedicine that is developing a new generation of nanomedicines through an innovative nanotransport system. โฆSee details»
InnoMedica - ONdrugDelivery
InnoMedica is a Swiss biopharmaceutical company focused on developing advanced drug delivery systems using nanotechnology. Its pipeline targets oncology and neurodegenerative โฆSee details»
InnoMedica โ Pharmaceuticals efficiently targeted
InnoMedica thereby wants to address the challenge of an efficient biodistribution of active agents in the human body while improving efficacy and reducing side effects. First applications in โฆSee details»
InnoMedica Company Profile - Office Locations, Competitors
InnoMedica has 5 employees across 3 locations. See insights on InnoMedica including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
InnoMedica - VentureRadar
Based on the liposomal technology platform, InnoMedica has built a diversified pipeline with lead compounds in oncology and neurodegenerative diseases. Talidox, a liposomal formulation of โฆSee details»
InnoMedica Holding AG - Drug pipelines, Patents, Clinical trials
InnoMedica has created a pioneering drug delivery system that allows for the targeted transportation of active pharmaceutical agents to the specific site of action, resulting in โฆSee details»
Über uns - InnoMedica
Die derzeit über 50 Mitarbeitenden von InnoMedica arbeiten in der Nanofactory in Marly bei Fribourg oder in den Büroräumlichkeiten in Bern. Bern ist Arbeitsort des Finanzteams sowie โฆSee details»
Unternehmen - InnoMedica
Bereits im Dezember 2017 hat InnoMedica die zweite Anwendung, die auf eine Behandlung von neurodegenerative Krankheiten wie Parkinson zielt, durch ein Patent geschützt und โฆSee details»
innomedica - biocomm.net
Parkinson's Disease Community Sponsor ABOUT INNOMEDICA Our Mission. Cutting-edge nanotechnology for the targeted treatment of diseases. Innovation in Service of Patients. โฆSee details»
Unsere Plattform - InnoMedica
InnoMedica's main focus is on the in-house development, manufacture, and production of medicines using the new nanotechnology. Many fundamentally effective active ingredients โฆSee details»